Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

4 Relative Price Strength Picks for Today's Stock MarketPhoto, wide shot, wide-angle lens,  Hedge fund, neutral atmosphere, photo by Charlie Waite: https://img.theapi.app/temp/95282efd-f725-49c0-be40-aa74627f7ccc.png
4 Relative Price Strength Picks for Today's Stock Market

The U.S. stock market seems to be heading in a positive direction, but it's likely to be a bumpy ride. The Federal Reserve's decision to leave interest rates as they are suggests that inflation is

Avnet's Q3 Earnings Beat Estimates on Record Components Sales
Avnet's Q3 Earnings Beat Estimates on Record Components Sales

Avnet, Inc. AVT reported better-than-expected third-quarter fiscal 2026 results. The company’s third-quarter adjusted earnings of $1.48 per share beat the Zacks Consensus Estimate by 11.28%. The

Woodward's Q2 Earnings & Revenues Beat Estimates, Increase Y/Y
Woodward's Q2 Earnings & Revenues Beat Estimates, Increase Y/Y

Woodward, Inc. WWD reported second-quarter fiscal 2026 adjusted net earnings per share (EPS) of $2.27, which jumped 34.3% year over year and beat the Zacks Consensus Estimate by 13.5%.

Quarterly net

CVS Q1 Earnings Preview: Health Services Likely to Lead Performance
CVS Q1 Earnings Preview: Health Services Likely to Lead Performance

CVS Health CVS is scheduled to report first-quarter 2026 results on May 6, before the market opens.

The company posted adjusted earnings per share (EPS) of $1.09 in the last reported quarter, which

Upbound Group (UPBD) Q1 Earnings Top Estimates
Upbound Group (UPBD) Q1 Earnings Top Estimates

Upbound Group (UPBD) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $1 per share a year ago. These figures

Wayfair (W) Q1 Earnings Match Estimates
Wayfair (W) Q1 Earnings Match Estimates

Wayfair (W) came out with quarterly earnings of $0.26 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.1 per share a year ago. These figures are adjusted for

TriNet Group (TNET) Q1 Earnings and Revenues Top Estimates
TriNet Group (TNET) Q1 Earnings and Revenues Top Estimates

TriNet Group (TNET) came out with quarterly earnings of $2.48 per share, beating the Zacks Consensus Estimate of $1.91 per share. This compares to earnings of $1.99 per share a year ago. These

Sirius XM (SIRI) Beats Q1 Earnings and Revenue Estimates
Sirius XM (SIRI) Beats Q1 Earnings and Revenue Estimates

Sirius XM (SIRI) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.7 per share. This compares to earnings of $0.59 per share a year ago. These figures

T. Rowe Price (TROW) Beats Q1 Earnings Estimates
T. Rowe Price (TROW) Beats Q1 Earnings Estimates

T. Rowe Price (TROW) came out with quarterly earnings of $2.52 per share, beating the Zacks Consensus Estimate of $2.37 per share. This compares to earnings of $2.23 per share a year ago. These

SunCoke Energy (SXC) Reports Q1 Loss, Beats Revenue Estimates
SunCoke Energy (SXC) Reports Q1 Loss, Beats Revenue Estimates

SunCoke Energy (SXC) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of $0.08. This compares to earnings of $0.2 per share a year ago. These figures are

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Tops Revenue EstimatesPhoto, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Tops Revenue Estimates

Phathom Pharmaceuticals, Inc. (PHAT) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $1.07 per share a year ago

Cartesian Therapeutics, Inc. (RNAC) Reports Q1 Loss, Lags Revenue Estimates
Cartesian Therapeutics, Inc. (RNAC) Reports Q1 Loss, Lags Revenue Estimates

Cartesian Therapeutics, Inc. (RNAC) came out with a quarterly loss of $1.46 per share versus the Zacks Consensus Estimate of a loss of $0.84. This compares to a loss of $0.68 per share a year ago

ProPetro Holding (PUMP) Reports Q1 Loss, Tops Revenue Estimates
ProPetro Holding (PUMP) Reports Q1 Loss, Tops Revenue Estimates

ProPetro Holding (PUMP) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to earnings of $0.09 per share a year ago. These

Option Care (OPCH) Q1 Earnings Beat Estimates
Option Care (OPCH) Q1 Earnings Beat Estimates

Option Care (OPCH) came out with quarterly earnings of $0.4 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.4 per share a year ago. These figures

Blue Owl Capital Inc. (OWL) Q1 Earnings Match Estimates
Blue Owl Capital Inc. (OWL) Q1 Earnings Match Estimates

Blue Owl Capital Inc. (OWL) came out with quarterly earnings of $0.19 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.17 per share a year ago. These figures

OneWater Marine (ONEW) Reports Q2 Loss, Misses Revenue Estimates
OneWater Marine (ONEW) Reports Q2 Loss, Misses Revenue Estimates

OneWater Marine (ONEW) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of $0.09. This compares to earnings of $0.13 per share a year ago. These figures are

NovoCure (NVCR) Reports Q1 Loss, Beats Revenue Estimates
NovoCure (NVCR) Reports Q1 Loss, Beats Revenue Estimates

NovoCure (NVCR) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.4. This compares to a loss of $0.31 per share a year ago. These figures are

Martin Marietta (MLM) Q1 Earnings and Revenues Beat Estimates
Martin Marietta (MLM) Q1 Earnings and Revenues Beat Estimates

Martin Marietta (MLM) came out with quarterly earnings of $1.93 per share, beating the Zacks Consensus Estimate of $1.76 per share. This compares to earnings of $1.9 per share a year ago. These

Altria (MO) Q1 Earnings and Revenues Surpass Estimates
Altria (MO) Q1 Earnings and Revenues Surpass Estimates

Altria (MO) came out with quarterly earnings of $1.32 per share, beating the Zacks Consensus Estimate of $1.24 per share. This compares to earnings of $1.23 per share a year ago. These figures are

LKQ (LKQ) Q1 Earnings Meet Estimates
LKQ (LKQ) Q1 Earnings Meet Estimates

LKQ (LKQ) came out with quarterly earnings of $0.67 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.79 per share a year ago. These figures are adjusted for

L3Harris (LHX) Q1 Earnings and Revenues Top Estimates
L3Harris (LHX) Q1 Earnings and Revenues Top Estimates

L3Harris (LHX) came out with quarterly earnings of $2.72 per share, beating the Zacks Consensus Estimate of $2.53 per share. This compares to earnings of $2.41 per share a year ago. These figures

Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Tops Revenue Estimates
Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Tops Revenue Estimates

Kymera Therapeutics, Inc. (KYMR) came out with a quarterly loss of $0.71 per share versus the Zacks Consensus Estimate of a loss of $0.89. This compares to a loss of $0.82 per share a year ago

Hippo Holdings Inc. (HIPO) Q1 Earnings Top Estimates
Hippo Holdings Inc. (HIPO) Q1 Earnings Top Estimates

Hippo Holdings Inc. (HIPO) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to a loss of $1.91 per share a year ago. These

Kirby (KEX) Beats Q1 Earnings and Revenue Estimates
Kirby (KEX) Beats Q1 Earnings and Revenue Estimates

Kirby (KEX) came out with quarterly earnings of $1.5 per share, beating the Zacks Consensus Estimate of $1.41 per share. This compares to earnings of $1.33 per share a year ago. These figures are

Indivior Pharmaceuticals Inc. (INDV) Q1 Earnings and Revenues Beat EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Indivior Pharmaceuticals Inc. (INDV) Q1 Earnings and Revenues Beat Estimates

Indivior Pharmaceuticals Inc. (INDV) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $0.41 per share a year